2916 N. MIAMI AVENUE, MIAMI, FL
Veru Inc. Enters $21.8 Million Sales Agreement with Oppenheimer & Co.
Other Events
Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Director Elections and Amendment to Equity Incentive Plan Approved
Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
Material Contracts, Other Events
News, Material Contracts
Q2
Q1
FY 2025
Q3
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Definitive Revised Proxy Statement
Correspondence
Submission Upload